Mraz Amerine & Associates Inc. Buys 2,022 Shares of CVS Health Co. (NYSE:CVS)

Mraz Amerine & Associates Inc. boosted its position in CVS Health Co. (NYSE:CVS) by 10.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 20,643 shares of the pharmacy operator’s stock after acquiring an additional 2,022 shares during the quarter. Mraz Amerine & Associates Inc.’s holdings in CVS Health were worth $1,298,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in CVS. Brookstone Capital Management raised its stake in shares of CVS Health by 3.3% during the first quarter. Brookstone Capital Management now owns 65,157 shares of the pharmacy operator’s stock worth $5,197,000 after acquiring an additional 2,054 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in CVS Health by 0.4% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 202,838 shares of the pharmacy operator’s stock valued at $16,178,000 after buying an additional 823 shares during the period. Financial Management Professionals Inc. grew its stake in shares of CVS Health by 14.8% during the first quarter. Financial Management Professionals Inc. now owns 3,948 shares of the pharmacy operator’s stock valued at $315,000 after buying an additional 508 shares during the last quarter. OneAscent Financial Services LLC increased its holdings in shares of CVS Health by 6.4% in the first quarter. OneAscent Financial Services LLC now owns 7,032 shares of the pharmacy operator’s stock worth $561,000 after buying an additional 425 shares during the period. Finally, Toth Financial Advisory Corp lifted its stake in shares of CVS Health by 2.2% in the 1st quarter. Toth Financial Advisory Corp now owns 80,459 shares of the pharmacy operator’s stock valued at $6,417,000 after acquiring an additional 1,740 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. Wells Fargo & Company increased their price objective on CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research note on Monday, August 12th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Mizuho lowered their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday. Royal Bank of Canada reissued an “outperform” rating and issued a $68.00 target price on shares of CVS Health in a research note on Wednesday, September 4th. Finally, Barclays cut their price objective on CVS Health from $82.00 to $75.00 and set an “overweight” rating on the stock in a research report on Wednesday. Nine investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $74.58.

CVS Health Stock Performance

Shares of CVS stock opened at $56.11 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. The company has a market capitalization of $70.44 billion, a price-to-earnings ratio of 9.86, a price-to-earnings-growth ratio of 0.93 and a beta of 0.54. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The company’s 50-day moving average is $59.88 and its 200 day moving average is $60.17.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. The company had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The firm’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter last year, the firm earned $2.21 earnings per share. Sell-side analysts expect that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.74%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.